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Abstract
Background: Early repolarization pattern (ERP) on electrocardiogram was associated with idiopathic ventricular fibrillation
and sudden cardiac arrest in a case-control study and with cardiovascular mortality in a Finnish community-based sample.
We sought to determine ERP prevalence and its association with cardiac and all-cause mortality in a large, prospective,
population-based case-cohort study (Monitoring of Cardiovascular Diseases and Conditions [MONICA]/KORA [Cooperative
Health Research in the Region of Augsburg]) comprised of individuals of Central-European descent.
Methods and Findings: Electrocardiograms of 1,945 participants aged 35–74 y, representing a source population of 6,213
individuals, were analyzed applying a case-cohort design. Mean follow-up was 18.9 y. Cause of death was ascertained by the
9th revision of the International Classification of Disease (ICD-9) codes as documented in death certificates. ERP-attributable
effects on mortality were determined by a weighted Cox proportional hazard model adjusted for covariables. Prevalence of
ERP was 13.1% in our study. ERP was associated with cardiac and all-cause mortality, most pronounced in those of younger
age and male sex; a clear ERP-age interaction was detected (p=0.005). Age-stratified analyses showed hazard ratios (HRs)
for cardiac mortality of 1.96 (95% confidence interval [CI] 1.05–3.68, p=0.035) for both sexes and 2.65 (95% CI 1.21–5.83,
p=0.015) for men between 35–54 y. An inferior localization of ERP further increased ERP-attributable cardiac mortality to
HRs of 3.15 (95% CI 1.58–6.28, p=0.001) for both sexes and to 4.27 (95% CI 1.90–9.61, p,0.001) for men between 35–54 y.
HRs for all-cause mortality were weaker but reached significance.
Conclusions: We found a high prevalence of ERP in our population-based cohort of middle-aged individuals. ERP was
associated with about a 2- to 4-fold increased risk of cardiac mortality in individuals between 35 and 54 y. An inferior
localization of ERP was associated with a particularly increased risk.
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The electrocardiographic pattern of early repolarization (ERP),
a slurring or notching at the QRS-ST junction, is a common and
long described finding on electrocardiogram (ECG) [1,2]. Its
prevalence has been assessed controversially, ranging between
1%–5%, and being more common in young athletic males [3–5].
Although generally considered benign, experimental studies
suggested an arrhythmogenic potential [6], and recent clinical
data demonstrated a strong association with ventricular fibrillation
and sudden cardiac death (SCD) in patients without structural
heart disease [7]. Recently, a community-based investigation of
Finnish individuals demonstrated a slightly increased cardiovas-
cular mortality associated with ERP [8].
Cardiovascular diseases are the main cause of death in the
industrialized world, and in approximately 50% of deaths due to
cardiovascular causes, SCD, mostly due to ventricular arrhythmi-
as, is considered the underlying reason [9,10]. Incidence rates
range between 50–100 per 100,000 residents depending on
definition and ascertainment of SCD in the investigated
population.
Here we sought to determine the prevalence of ERP in a large
population-based cohort (Monitoring of Cardiovascular Diseases
and Conditions [MONICA]/KORA [Cooperative Health Re-
search in the Region of Augsburg] study) of individuals of Central-
European descent in the age range between 35–74 y and to
investigate its potential association with cardiac and all-cause
mortality using follow-up information of more than two decades.
In addition, we performed age- and sex-stratified analyses.
Methods
Study Population and Mortality Follow-Up
We performed a prospective case-cohort study on the basis of the
World Health Organization’s population-based German MONICA
study in Augsburg. We investigated the two independent, cross-
sectional surveys S1 (1984–1985) and S2 (1989–1990) that were
performed in the region of Augsburg, Southern Germany, and
comprised 8,962 participants (4,505 men; 4,457 women) [11,12].
Because cardiovascular mortality is low at younger ages, analysis
was restricted to individuals aged 35–74 y, yielding a source
population of 6,213 individuals (3,035 men; 3,178 women).
Following the case-cohort design [13,14], a representative
random sample of the entire source population was drawn
(referred to below as the subcohort), stratified by sex and survey
as described elsewhere [15–17]. It was enriched with all
participants who died during follow-up. Primary analysis focused
on cardiac mortality. Individuals were excluded if no electrocar-
diogram (ECG) was available (n=95). We further excluded
individuals with significant ventricular conduction delay
(QRS.120 ms, n=94), atrial fibrillation (n=21), and implanted
pacemaker (n=4). Thereafter, the case-cohort population consist-
ed of 1,945 individuals. This total included a random sample of
1,583 participants representative for the entire source population
and, in addition, all those who died of cardiac (n=511) or any
causes (n=1,496) during follow-up.
All individuals gave written informed consent to participation in
the KORA study, approved by the Ethics Committee of the
Bavarian Medical Association (Bayerische A ¨rztekammer) and the
Bavarian commissioner for data protection and privacy (Bayer-
ischer Datenschutzbeauftragter), and adhering to the principles
outlined in the Declaration of Helsinki.
All participants were prospectively followed on a regular basis
within the framework of KORA and follow-up information was
available until December 2007 [12]. In case of death, death
certificates were obtained from local health departments and
evaluated using the 9th revision of the International Classification
of Diseases (ICD-9). Death of cardiac causes was assumed for
ICD-9 codes 390–429 and 798.
ECG Recording and Definition of ERP
Study participants received 12-lead resting ECGs (Sicard 803
ECG system, Siemens), applying a standardized protocol after 10-
min rest in a supine position. ECGs were recorded at the initial
study visit. Routine ECG parameters were obtained from
automated measurements.
ERP was assessed manually in all ECGs using paper prints.
Quantitative measurements were performed by ruler-based visual
inspection using Spacelab magnifying glasses for ECG diagnostics.
The criteria for detection of ERP were exactly as recently
described by Haı ¨ssaguerre and colleagues [7]. Briefly, classification
as ERP required a J-point elevation $0.1 mV in $2 adjacent
leads with either slurring or notching morphology. Leads V1 to V3
were not interpreted to avoid confusion with ECG patterns of
Brugada-syndrome or right ventricular dysplasia. Presence or
absence of ST-elevation in addition to J-point elevation was not
taken into account and nonspecific intraventricular conduction
delay was excluded from analysis.
Two trained cardiologists from different centers, blinded to
clinical data and follow-up status, independently assessed all
ECGs. In case of divergent results, a third blinded cardiologist
reinterpreted the ECG, and a preliminary decision on ERP status
was achieved by majority vote. There was a moderate to
substantial strength of agreement between the two initial
interpreters (k=0.521, proportion agreement 0.82). A total of
483 (23.4%) ECGs were judged by the third cardiologist. After
preliminary decision on ERP status, two trained cardiologists
jointly reassessed all ECGs that were considered ERP-positive, and
a final decision on ERP status was reached by consensus.
Statistical Analysis
Statistical analyses were performed with ‘‘R’’ (R Foundation for
Statistical Computing), applying a case-cohort model using the
robust variance estimation method, which is a weighted analysis
design [13]. Sex- and survey-stratified sampling weights within the
subcohort were: S1: men, 2.78, women, 4.03; S2: men, 4.20,
women, 4.97.
Baseline characteristics were expressed as means or proportions
as appropriate and compared between groups. The effect of ERP
on covariables was tested by linear regression for continuous
variables or logistic regression for dichotomous variables.
The relationship between ERP and mortality was calculated
using a weighted Cox proportional hazards model [18], and
visualized by Kaplan-Meier plots. All results were adjusted for
covariables by multivariate analyses. Covariables included age,
sex, and survey, or additionally a series of clinical characteristics.
In case of age- and/or sex-stratified analyses, no further
adjustment was performed for the respective variables. An
interaction term (ERP6age) was included to determine age-
dependent effects. With ERP coded as dummy variable and age
recoded to reference age 35 y, this term indicates an additional
change of the effect size with each year of age above 35, which
only applies for participants with ERP. To better illustrate the age-
dependent effect of ERP, we also performed age- and sex-stratified
subgroup analyses with age groups defined as 35–54, 55–64, and
65–74 y.
Because of the long-term follow-up and the design of the study,
violation of the proportional hazards assumption was likely to
ERP Prevalence and Mortality
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proportional hazards regression to vary with age group, sex,
survey, and smoking status. The latter was identified to have a
strongly time-dependent effect on mortality using a test based on
scaled Schoenfeld residuals [19]. For consistency, this adjustment
was kept throughout all subgroup analysis. The QT interval was
corrected according to the Framingham formula [20]. Statistical
significance was considered for a two-sided p-value of ,0.05.
Results
After application of exclusion criteria, we present weighted
results for the entire source population of 6,213 individuals from
surveys S1 and S2 with a male proportion of 48.9% and a mean
age of 52.0 y. Detailed clinical characteristics are depicted in
Table 1. Discrepancies between ERP-positive and -negative
individuals were detected for age, smoking status, diabetes
mellitus, and high-density lipoprotein (HDL) cholesterol. There
were no significant differences in clinical characteristics in those
who died of cardiac causes compared to survivors. In individuals
that died of any cause during follow-up, ERP-positive individuals
included a higher proportion of smokers and had a lower
prevalence of congestive heart failure.
At baseline, cardiovascular risk factors were significantly more
prevalent in deceased individuals than in survivors.
Prevalence of ERP
In our study population, the overall prevalence of ERP was
13.1%. ERP was more common in men. It was more prevalent in
individuals deceased from cardiac causes. ERP was found
predominantly in antero-lateral leads (4.4%) or inferior leads
(7.6%) (Table 2). In 1.0%, ERP was present in a combination of
antero-lateral and inferior leads. A slurring or notching morphol-
ogy was present in 9.5% and 3.5%, respectively. These
proportions remained stable among sexes. Representative exam-
ples of ERP in our study population are shown in Figure 1.
Association of ERP with Cardiac and All-Cause Mortality
Follow-up information was available for a mean duration of
18.9 y (0.03–23.2 y). During this period, 511 individuals died from
cardiac causes, of which 345 (67.5%) were of male sex and 89
(17.4%) presented with ERP. A total of 1,496 participants
deceased of any cause, of which 932 (62.3%) were male and 244
(16.3%) presented with ERP (Table 2).
We detected a robust relationship between ERP and cardiac
mortality. ERP-attributable effects on mortality showed strong
age-dependence. Accounting for age-dependence by incorporating
an interaction term between ERP and age (ERP6age), we found
associations between ERP and cardiac mortality that persistently
remained significant after adjusting for age, sex, and survey, or
additional clinical risk factors. This effect faded with increasing
age. The strongest effects reached an age-dependent hazard ratio
(HR) of up to 3.44, which was reduced per additional year of age
(Tables 3 and S1).
In age-stratified analyses, in the lowest age-group (35–54 y), we
found a persistent and hazardous effect of ERP on cardiac
mortality for both sexes (HR 1.96, 95% confidence interval [CI]
1.05–3.68, p=0.035) and males only (HR 2.65, 95% CI 1.21–
5.83, p=0.015). Effects were less pronounced in women, where
results failed to reach statistical significance (Figure 2A, 2C;
Tables 3 and S1). In middle-aged participants (55–64 y), ERP
appeared to have no relevant effect on mortality (Figure 2A;
Tables 3 and S1).
When stratifying for localization of ERP, we found that an
inferior distribution conferred the strongest risk for cardiac
mortality in an interaction analysis with age, reaching an age-
dependent HR of 3.71. In the age-stratified analysis of 35–54-year-
old participants, the HR was 3.15 (95% CI 1.58–6.28, p=0.001)
for both sexes and 4.27 (95% CI 1.90–9.61, p,0.001) for males
only (Figure 2B, 2D; Tables 3 and S1). No relevant effect was
determined for antero-lateral distributions of ERP (unpublished
data).
The effect of ERP on all-cause mortality was generally weaker,
but followed the same pattern as compared to the effect on cardiac
mortality. For ERP in any localization, significant associations
were observed in an age-dependent analysis of both sexes and in
the age-group of 35–54-y-old males. Restricting the analysis to
ERP localized in inferior leads, we found significant findings in
both an age-dependent and age-stratified model for both sexes
combined and males only. Detailed results on all-cause mortality
can be derived from Tables 4 and S2.
Table 2. ERP prevalence and mortality.
ERP Prevalence n (%) n Study Population (%) n Death from Cardiac Causes (%) n Death from Any Cause (%)
Total n 6,213 511 1,496
Overall 812 (13.1) 89 (17.4) 244 (16.3)
Antero-lateral leads 275 (4.4) 25 (4.9) 78 (5.2)
Inferior leads 474 (7.6) 58 (11.4) 149 (10.0)
Combined antero-lateral and inferior leads 63 (1.0) 6 (1.2) 17 (1.1)
Slurring morphology 590 (9.5) 58 (11.4) 161 (10.8)
Notching morphology 219 (3.5) 31 (6.1) 83 (5.6)
Men 439 (7.1) 60 (11.7) 160 (10.7)
Women 372 (6.0) 29 (5.7) 84 (5.6)
35–54 y 422 (11.9) 20 (19.0) 57 (15.4)
55–64 y 277 (14.3) 51 (20.8) 120 (18.0)
65–74 y 114 (15.6) 18 (11.2) 67 (14.6)
Data are displayed in absolute numbers (with percent in parentheses) and present the prevalence of ERP in the study population and in individuals deceased from
cardiac or any causes.
doi:10.1371/journal.pmed.1000314.t002
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In our study, we determined the prevalence of ERP to be 13.1%
in the overall sample. Using long follow-up, we were able to
demonstrate a strong association between ERP and cardiac
mortality. This association was strongest for the presence of
ERP in inferior leads of the ECG and restricted to men between
35–54 y of age. Here, the HR was 4.32. To a lesser extent, we also
detected an association between ERP and all-cause mortality.
This study determined the prevalence of ERP in a large
population-based sample. The overall prevalence of ERP was
13.1%, and men were more frequently affected than women. This
finding contrasts previous publications reporting a prevalence
between 1%–5% [3–5]. These studies were derived from large
patient or volunteer samples of 60,000 and 73,000 individuals,
respectively, and recently from a population-based study in Finland
where the prevalence of ERP was 5.8% [8]. This latter cohort
was recruited from various sites across Finland and thus might
represent individuals of Northern-European descent only. Our
population, however, is of Central-European descent and was
homogeneously recruited from a well-defined single region of
Southern Germany. Another Western-European population in
France evaluated females only and reported an ERP prevalence of
17.2% [21].
Figure 1. Representative examples of ERP from our study population. (A) shows a slurring morphology, whereas a notching morphology
predominates in (B) and (C). Arrows point to leads where ERP can be identified most clearly.
doi:10.1371/journal.pmed.1000314.g001
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based, studies reporting the prevalence of ERP found 25% and
16% in men and women, respectively [2]. Importantly, definition
of ERP was heterogeneous across studies. Our results strictly relied
on the definition by Haı ¨ssaguerre and colleagues [7], and support
the clinical experience that ERP is indeed a common ECG
signature in every-day practice.
Our study found an association of ERP with both cardiac and
all-cause mortality. ERP was most pronounced in younger
individuals, particularly in males, where the ERP-associated
cardiac risk was found to be increased 2–4-fold. For many years
ERP was considered a benign phenomenon. However, this
judgment was seriously questioned by both (1) a study, in which
ERP was found to be a clinically relevant ECG signature, and
possibly a marker of SCD, in the evaluation of unexplained
syncope or idiopathic ventricular fibrillation in patients without
structural heart disease [7], and (2) the recent report associating
ERP with cardiovascular mortality in a Finnish community-based
population [8]. A difference between the initial clinical report, the
recent population-based study, and our study are the investigated
populations. While Haı ¨ssaguerre and coworkers presented results
of selected SCD-survivors, and the initial population-based study
reported on a Northern-European population, we report here on a
large community-based cohort of individuals of Central-European
origin. However, all of these recent studies applied the same
definition of ERP, making the results comparable. Furthermore, in
the Finnish study [8] and in our investigation, the ECGs were
recorded prospectively, before the occurrence of events, and in
both, ERP was found more frequently in males. Our study
provides evidence from the general population supporting the
hypothesis that ERP is a marker for increased risk for cardiac
mortality. These findings support the results by Tikkanen and
colleagues, where a slightly increased risk for cardiovascular
mortality was shown in an unstratified sample applying a
comparable definition of ERP [8]. A hazardous effect of ERP is
further suggested by the fact that an association can still be
detected looking at all-cause mortality, although the effect size and
association strength are much more pronounced when investigat-
ing cardiac mortality only.
In addition to the previous reports, our study further refines the
association of ERP with cardiac mortality, demonstrating an
association between ERP and cardiac mortality predominantly in
younger individuals. SCD occurs in approximately 50% of all
cardiovascular deaths [10]. Coronary artery disease is the main
underlying disease primarily in the elderly, while in younger
individuals SCD without underlying structural heart disease is
more common [10]. For these reasons, a pathophysiologic link
between ERP and malignant arrhythmias seems plausible, and
would suggest that ERP-attributable death occurred without
underlying structural defect. However, the cause of death in our
study was determined from death certificates only. Thus, there is a
possible bias towards common causes of death. Yet, in the context
of structural heart disease, ERP could modify the risk for
malignant arrhythmias. Additionally, the attenuated association
between ERP and cardiovascular mortality in older age groups
might be attributed to an increased prevalence and relevance of
classical risk factors. Our results were therefore adjusted for a
variety of cardiovascular risk factors, and the association between
Table 3. Association of ERP with cardiac mortality.
Study Population Substrata ERP in any Localization ERP in Inferior Localization
HR (95% CI) p-Value HR (95% CI) p-Value
All
Main effect ERP 3.44 (1.52–7.80) 0.003 3.71 (1.44–9.53) 0.007
ERP 6age 0.95 (0.92–0.99) 0.005 0.96 (0.92–1.00) 0.049
Age-strata 35–54 y 1.96 (1.05–3.68) 0.035 3.15 (1.58–6.28) 0.001
55–64 y 1.12 (0.70–1.78) 0.63 1.33 (0.78–2.27) 0.29
65–74 y 0.59 (0.25–1.44) 0.25 1.18 (0.48–2.92) 0.72
Women
Main effect ERP 5.97 (0.85–42.04) 0.073 1.58 (0.14–17.42) 0.71
ERP 6age 0.93 (0.86–1.00) 0.56 0.99 (0.90–1.09) 0.91
Age-strata 35–54 y 1.25 (0.34–4.58) 0.73 1.48 (0.30–7.29) 0.63
55–64 y 0.99 (0.39–2.50) 0.99 1.80 (0.57–5.63) 0.32
65–74 y 0.63 (0.15–2.72) 0.54 0.77 (0.10–6.14) 0.81
Men
Main effect ERP 2.69 (1.10–6.60) 0.030 4.32 (1.59–11.68) 0.004
ERP 6age 0.96 (0.93–1.00) 0.058 0.96 (0.92–1.00) 0.039
Age-strata 35–54 y 2.65 (1.21–5.83) 0.015 4.27 (1.90–9.61) ,0.001
55–64 y 1.16 (0.67–2.02) 0.60 1.28 (0.67–2.42) 0.45
65–74 y 0.67 (0.21–2.08) 0.49 0.77 (0.10–6.14) 0.81
Association of ERP with cardiac mortality is displayed for both ERP and for an ERP localization restricted to inferior leads. Results are shown for the entire study
population, and separated for women and men. Results for the main effect are derived from a weighted Cox-proportional hazards model-based pooled analysis of the
entire study population, incorporating an ERP-age interaction term (ERP6age) to account for age-dependence of ERP. Results for three different age-strata are shown.
All calculations are adjusted for sex, age, and survey and for the following clinical covariables: body mass index, total cholesterol/HDL cholesterol ratio, arterial
hypertension, nicotine abuse, congestive heart failure, prior myocardial infarction, diabetes mellitus, heart rate, and QTc. In case of age- and/or sex-stratified analyses, no
further adjustment was performed for the respective variables.
doi:10.1371/journal.pmed.1000314.t003
ERP Prevalence and Mortality
PLoS Medicine | www.plosmedicine.org 6 July 2010 | Volume 7 | Issue 7 | e1000314Figure 2. ERP effects on cardiac mortality. (A) HRs and CIs for ERP in any localization. (B) HRs and CIs for the analysis restricted to ERP in an
inferior localization. In both (A) and (B), the symbols illustrate the effect size as derived from an age-stratified analysis in younger (35–54 y), middle-
aged (55–64 y), and older (65–74 y) participants. Comparing (A) and (B), the ERP-attributable effect is more pronounced if localized in inferior leads.
The lower panels show Kaplan-Meier curves for cardiac mortality depending on the presence of ERP and sex in the subgroup of younger individuals
(35–54 y). (C) Kaplan-Meier curves for ERP in any localization. (D) Kaplan-Meier curves for ERP in an inferior localization. Men with ERP show the
highest cumulative hazard. The effect of ERP on cardiac mortality is stronger in men and outweighs the sex-attributable effect. ERP-attributable
effects tend to start earlier in men than in women. Again, effects are stronger, restricting the analysis to an inferior localization of ERP. p-Values in (C
and D) were derived by a weighted Cox proportional hazards model. The numbers of individuals at risk are listed below each Kaplan-Meier plot.
doi:10.1371/journal.pmed.1000314.g002
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thereafter.
A sex-stratified analysis revealed a particularly strong association
of ERP with cardiac mortality in males. Conflicting data exist as to
the predominance of sex in SCD and sudden unexplained death
(SUD). Against the general notion that SUD is more common in
men—autopsy series reported 63%–68% males [22,23]—the
Edwards Registry of Cardiovascular Death found a clear female
predominance for SUD (32% and 24% for women and men,
respectively). After detailed review, the rates of SCD in these
individuals were 50% in women versus 24% in men [24]. A study in
female army recruits found SUD to be attributable to 53% of
sudden deaths [25]. This trend towards women holds true also in
the context of ischemic events. Dekker and colleagues showed that
women tended to present more often with ventricular fibrillation in
the context of a first myocardial infarction than men (21.8% versus
16.7%, p=0.084) [26]. Our data, as well as the previous report by
Tikkanen and colleagues [8], demonstrate a higher prevalence of
ERP in men, which is associated with higher cardiac and all-cause
mortality. This result suggests that, among all causes of SCD, ERP
might be a risk factor for SCD predominantly in males.
The potentially hazardous nature of ERP is also supported by
experimental, electrophysiological data [6]. A transmural hetero-
geneity, primarily generated by the Ito-channel, underlies the
presence of ERP on the surface ECG. This transmural gradient is
caused by an epicardial but not endocardial depression of the
action potential plateau. Compared to arrhythmogenic entities like
the Brugada syndrome, in ERP this gradient is relatively weak, but
can be aggravated by certain triggers like drugs, vagal tone, or
electrolyte shifts. This tendency might lead to the interpretation
that ERP is not a malignant condition per se, but rather represents
a susceptibility marker for malignant arrhythmias, possibly in the
context of a triggering event. Further research is warranted to
identify potential triggers. As seen for a number of other ECG
signatures, for example QT- or PR-interval [27–29], among other
factors, there might also be a heritable component, explaining part
of the variable occurrence of ERP in the population or the degree
of arrhythmogenicity.
With regard to the clinical impact of ERP, a careful
interpretation is required. Younger males (35–54 y) in our study
appear to bear the highest risk. However, the maximum risk
attributed to ERP might be overestimated because of low
incidence of cardiac deaths in the younger age groups. ERP is
associated with a 2–4-fold increased risk, which parallels the
findings for the risk of cardiovascular mortality attributed to
established ECG parameters. In the Rotterdam Study, a
prolonged QTc interval conferred a HR between 1.3 and 2.4
for men and women, respectively [30]. In a study analyzing the
risk of SCD, an abnormally long QTc ($450 ms in men;
$470 ms in women) was associated with a 2.6-fold increased risk
in men and 2.5-fold in women, while younger participants
appeared to be at higher risk [31]. For resting heart rate .75
beats/min, the Paris Prospective Study reported a maximum HR
of 3.5 for SCD [32]. Both QT prolongation and resting heart rate
found their way into clinical routine, as the ECG is a diagnostic
tool widely used in clinical practice. Yet, the impact of QTc or
heart rate is still low in otherwise asymptomatic individuals, unless
extreme values are detected, family history of SCD is positive, or
Table 4. Association of ERP with all-cause mortality.
Study Population Substrata ERP in any Localization ERP in Inferior Localization
HR (95% CI) p-Value HR (95% CI) p-Value
All
Main effect ERP 1.87 (1.03–3.37) 0.038 2.17 (1.11–4.23) 0.023
ERP 6age 0.97 (0.95–1.00) 0.041 0.98 (0.95–1.01) 0.11
Age-strata 35–54 y 1.39 (0.95–2.03) 0.095 1.80 (1.15–2.81) 0.010
55–64 y 1.00 (0.71–1.40) 0.98 1.18 (0.79–1.77) 0.41
65–74 y 0.77 (0.41–1.45) 0.42 0.13 (0.58–2.20) 0.71
Women
Main effect ERP 2.05 (0.62–6.82) 0.24 1.24 (0.30–5.17) 0.77
ERP 6age 0.96 (0.91–1.01) 0.12 0.99 (0.93–1.05) 0.63
Age-strata 35–54 y 0.97 (0.49–1.91) 0.92 0.94 (0.42–2.08) 0.88
55–64 y 0.74 (0.37–1.48) 0.40 1.00 (0.44–2.28) 1.00
65–74 y 0.60 (0.23–1.56) 0.30 0.51 (0.16–1.69) 0.27
Men
Main effect ERP 1.67 (0.85–3.30) 0.14 2.62 (1.24–5.57) 0.012
ERP 6age 0.98 (0.95–1.01) 0.26 0.97 (0.94–1.01) 0.15
Age-strata 35–54 y 1.88 (1.15–3.08) 0.012 2.80 (1.61–4.88) ,0.001
55–64 y 1.11 (0.74–1.67) 0.61 1.35 (0.83–2.20) 0.23
65–74 y 1.02 (0.42–2.48) 0.96 1.55 (0.58–4.13) 0.29
Association of ERP with all-cause mortality is displayed for both ERP and for an ERP localization restricted to inferior leads. Results are shown for the entire study
population, and separated for women and men. Results for the main effect are derived from a weighted Cox-proportional hazards model-based pooled analysis of the
entire study population, incorporating an ERP-age interaction term (ERP6age) to account for age-dependence of ERP. Results for three different age-strata are shown.
All calculations are adjusted for sex, age, and survey and for the following clinical covariables: body mass index, total cholesterol/HDL cholesterol ratio, arterial
hypertension, nicotine abuse, congestive heart failure, prior myocardial infarction, diabetes mellitus, heart rate, and QTc. In case of age- and/or sex-stratified analyses, no
further adjustment was performed for the respective variables.
doi:10.1371/journal.pmed.1000314.t004
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detection of ERP on a routine ECG screen in an asymptomatic
individual with a negative family history for SCD does not need to
be followed up by a work-up or even prophylactic therapy. In this
context, in accordance with Tikannen and colleagues, we propose
to pay special attention to individuals with ERP in inferior leads.
In addition there is evidence that the currently applied threshold
for ERP ($0.1 mV) appears to be too low [8]. We aimed at
substantiating this notion; however, our study sample was not
adequately powered to reliably perform an analysis with an
elevated ERP threshold.
Strengths and Limitations
A major strength of our study is the use of the MONICA/
KORA cohort being characterized by long follow-up and detailed
risk factor and ECG information. The case-cohort design provides
an efficient and unbiased sample of the entire cohort [13,14].
Likewise, the systematic and blinded fashion of the ECG analysis
can be considered a strong point.
However, several limitations merit discussion. A weakness is the
ascertainment of death by death certificates only. As discussed
above, a reliable differentiation can be made between cardiovas-
cular and noncardiovascular causes. However, within cardiovas-
cular causes, a more accurate differentiation is often not feasible.
We aimed to enrich cases of cardiac death within the spectrum of
cardiovascular causes of death, but it will require further studies to
narrow down the real underlying causes of death to foster the
hypothesis of a presumably arrhythmic death due to ERP.
Another limitation is the strictly epidemiologic nature of our
investigation. Consequently we cannot further clarify the patho-
physiologic and pathogenetic circumstances underlying ERP.
Inherent to our study design, we cannot comment on the influence
of ERP outside the age range of 35–74 y. Further research is
warranted to elucidate the impact of ERP in younger individuals.
Repetitive recordings of ECGs in the same individuals are
currently not available. We thus cannot comment on whether
ERP is a permanent or transient ECG pattern. However,
Tikkanen and colleagues reported persistence of ERP in .80%
of repeated ECG recordings [8].
In conclusion, we report a high prevalence of ERP in the
general population. Moreover, we found a robust association of
ERP with cardiac, and to a lesser degree, all-cause mortality in
participants between ages 35–54 y. The ERP-associated risk was
in the range of that conferred by prolonged QTc or elevated
resting heart rate in the general population. There is evidence that
a localization of ERP in inferior leads is associated with the highest
risk.
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Background. Cardiovascular diseases—disorders that affect
the heart and the circulation—are the leading cause of death
in the developed world. About half of cardiovascular deaths
occur when the heart suddenly stops pumping (sudden
cardiac arrest). The muscular walls of the four heart chambers
contract in a set pattern to pump blood around the body. The
heart’s internal electrical system controls the rate and rhythm
of these contractions and, if this system goes wrong, an
abnormal heart beat or ‘‘arrhythmia’’ develops. Some
arrhythmias—in particular, ventricular fibrillation in which
the walls of thetwolower heart chambers quiveror ‘‘fibrillate’’
instead of pumping—can cause sudden cardiac arrest and
immediate loss of consciousness. Death follows within
minutes in 95% of cases but immediate cardiopulmonary
resuscitation (CPR; chest compression to pump the heart and
inflation of the lungs by mouth-to-mouth resuscitation) can
keep a person alive until a defibrillator can be used to restore
the normal heart beat. People who survive sudden cardiac
arrest can be given anti-arrhythmia drugs or have a
pacemaker implanted to stabilize their heart beat.
Why Was This Study Done? The beating heart generates
tiny electric waves that can be detected by electrodes on the
skin. The pattern of these waves (an electrocardiogram or ECG)
provides information about the heart’s health. One wave
pattern that is often seen on ECGs is the ‘‘early repolarization
pattern’’ (ERP), which some studies suggest is associated with
an increased risk of cardiac death. Here, the researchers
investigate the prevalence of ERP (the proportion of a
population with ERP) and its association with death from
heart-related problems (cardiac mortality) and from any cause
(all-cause mortality) in the MONICA/KORA prospective,
population-based case-cohort study. The MONICA Project
(MONitoring of Trends and Determinants in CArdiovascular
Disease) has studied cardiovascular disease in 10 million people
in 21 countries; KORA denotes the study done in the Augsburg
region of Germany. In a prospective study, specific baseline
characteristics of the study’s participants are determined and
the participants are followed to see who experiences a
predefined outcome. A case-cohort study investigates a
randomly selected subcohort (subgroup) of the original
participants of a study and any participants who experience
the predefined outcome instead of all the participants.
What Did the Researchers Do and Find? Theresearchers
selected 1945 MONIKA/KORA participants aged 35–74 years
from a source population of about 6,000 people using a case-
cohort study design. They analyzed the ECGs (recorded in
1984–1985 or 1989–1990) of this subcohort and ascertained
the cause of death for those participants who died during the
18.9 year average follow-up. The overall prevalence of ERP in
the study was 13.1%, report the researchers, and ERP was
associated with cardiac mortality, particularly among younger
and male participants. Specifically, among men and women
aged 35–54 years, having ERP was associated with a nearly
doubled risk of cardiac death. Among men aged 35–54 years,
having ERP was associated with an increase in the risk of
cardiac death by 2.65-fold. An ERP localized to the bottom of
the heart (inferior localization) was associated with an
increased risk of cardiac death among both sexes by more
than 3-fold and among men by more than 4-fold in this age
group. Finally, ERP was also significantly associated with an
increased risk of all-cause mortality but less strongly than with
cardiac mortality.
What Do These Findings Mean? These findings suggest
that the prevalence of ERP among the middle-aged people
in the MONICA/KORA study is high (and somewhat higher
than previously reported). They also show a clear association
between ERP and the risk of cardiac death among 35–54-
year-old people, particularly among men, but because of the
study design, these findings do not show that ERP actually
causes cardiac death; it could simply be a susceptibility
marker. The researchers note that the increased risk of
cardiac death associated with ERP is of a similar size to that
associated with some other ECG abnormalities. However,
although it might be worth paying special attention to
young people with an inferior localization of ERP, finding ERP
in a person without symptoms and without a family history
of sudden cardiac death should not lead to further
investigations or any preventative therapy, they suggest,
because the absolute risk of cardiac arrest in such people is
very low.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000314.
N The US National Heart Lung and Blood Institute provides
information on cardiovascular conditions, including sud-
den cardiac arrest and on arrhythmias
N The American Heart Association also information on
sudden cardiac death and on arrhythmias
N The German Cardiac Society (Deutsche Gesellschaft fu ¨r
Kardiologie) and the German Heart Foundation (Deutsche
Herzstiftung) provide further information (in German) on
cardiovascular conditions
N The Heart Rhythm Foundation provides information on all
aspects of heart arrhythmia
N The Fondation Leducq Alliance Against Sudden Cardiac
Death provides information on sudden cardiac arrest
N MedlinePlus provides links to other resources about
cardiac arrest and arrhythmias (in English and Spanish)
N The MedlinePlus Encyclopedia has a page on electrocar-
diograms (in English and Spanish)
N The Nobel Foundation provides an interactive electrocar-
diogram game
N More information about the MONICA project and the
KORA Study or is available
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